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Abstract
Background: Prenatal environmental factors might influence the risk of developing cardiovascular disease later in life. The
HDL-associated enzyme paraoxonase 1 (PON1) has anti-oxidative functions that may protect against atherosclerosis. It also
hydrolyzes many substrates, including organophosphate pesticides. A common polymorphism, PON1 Q192R, affects both
properties, but a potential interaction between PON1 genotype and pesticide exposure on cardiovascular risk factors has
not been investigated. We explored if the PON1 Q192R genotype affects cardiovascular risk factors in school-age children
prenatally exposed to pesticides.
Methods: Pregnant greenhouse-workers were categorized as high, medium, or not exposed to pesticides. Their children
underwent a standardized examination at age 6-to-11 years, where blood pressure, skin folds, and other anthropometric
parameters were measured. PON1-genotype was determined for 141 children (88 pesticide exposed and 53 unexposed).
Serum was analyzed for insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP3), insulin and
leptin. Body fat percentage was calculated from skin fold thicknesses. BMI results were converted to age and sex specific Z-
scores.
Results: Prenatally pesticide exposed children carrying the PON1 192R-allele had higher abdominal circumference, body fat
content, BMI Z-scores, blood pressure, and serum concentrations of leptin and IGF-I at school age than unexposed children.
The effects were related to the prenatal exposure level. For children with the PON1 192QQ genotype, none of the variables
was affected by prenatal pesticide exposure.
Conclusion: Our results indicate a gene-environment interaction between prenatal pesticide exposure and the PON1 gene.
Only exposed children with the R-allele developed adverse cardiovascular risk profiles thought to be associated with the R-
allele.
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Introduction
The serum enzyme paraoxonase 1 (PON1) is a high density
lipoprotein (HDL)-associated enzyme with antioxidant function
[1]. It protects lipoproteins from oxidative modifications, and thus
protects against the development of atherosclerosis [2,3]. It also
catalyzes the hydrolysis of a wide range of substrates including the
toxic oxon metabolites of several organophosphates and therefore
provides some protection against chronic exposure to these
pesticides [4,5].
Several polymorphisms in PON1 have been identified [6,7]. A
common polymorphism in the coding sequence, a glutamine
(Q)/arginine(R) substitution at position 192, affects the catalytic
capacity toward pesticides [5,8], and also the anti-atherogenic
properties [2]. Hence, an association between the R-allele and
the risk of developing cardiovascular disease (CVD) has been
reported in case-control studies [2,9,10]. The ability of PON1 to
protect against both organophosphate toxicity and atherosclero-
sis is also supported by experimental studies, since PON1-
knockout mice were more sensitive to the toxic effects of
chlorpyrifos, and developed atherosclerosis when fed a high-fat
diet [11]. Although the PON1 Q192R genotype seems to affect
both the catalytic activity and the anti-atherogenic properties,
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the potential interaction between this genotype and pesticide
exposures on cardiovascular risk factors has not been investi-
gated.
We recently reported lower birth weight followed by an
increased body fat accumulation from birth to school age in
children whose mothers were exposed occupationally to modern
non-persistent pesticides in early pregnancy [12]. In this cohort of
children, we have determined the PON1 genotype to investigate
possible interactions between PON1 Q192R polymorphism and
prenatal pesticide exposure on risk markers for development of
CVD later in life.
Methods
Study Population and Design
This study is a part of an ongoing prospective study of the effects
of pesticide exposure in early pregnancy on the growth and
development in the children. From 1996 to 2000 pregnant women
working in greenhouses and referred to the Department of
Occupational Health at Odense University Hospital in Denmark
for advice regarding their working conditions during pregnancy,
were recruited consecutively [13]. Their children were examined
for the first time at three months of age [13] and followed up at
school age [12].
At enrolment (gestational weeks 4–10), detailed information
about working conditions, pesticide use and exposure was
obtained from maternal interviews and supplemented by tele-
phone contact to the employers. For all women, re-entry activities
(such as moving or packing pot plants or nipping cuttings)
constituted their main work functions. Approximately 20% of the
women reported to have been directly involved in applying
pesticides, mainly by irrigating fungicides or growth retardants.
Only few (6%) of the women had applied insecticides.
The total pesticide exposure level was categorized independently
(withagreement inall cases)by twotoxicologistswith special expertise
in working conditions in greenhouse horticultures into three groups:
none/low (controls), medium, and high as previously described
[12,14]. The exposure classification was performed before the first
examination of children. Approximately 200 different pesticide
formulations, representing 124 different active pesticide ingredients,
were used in the working areas. Some were used only in few
greenhouses or during restricted time periods, whereas, others were
used more often. Three organophosphates: dichlorvos, dimethoate,
and chlorpyriphos, were among the 20 most frequently used
pesticides, and twelve other organophosphates were used less
frequently. For most (91%) of the women rated as pesticide exposed,
organophosphates had been used in the working area, but the time
interval between applying insecticides and working in the treated
areas was longer (1–3 days) than for fungicides and growth regulators
(often a few hours).Hence, the re-entry exposurewas regarded higher
for fungicides and growth regulators than for insecticides. Women
categorizedaspesticideexposed,wentonpaid leaveorweremovedto
work functions with less or no pesticide exposure shortly after
enrollment. Hence, pesticide exposure mainly occurred early in
pregnancy.
A total of 168 children were categorized as prenatally pesticide
exposed, and 35 children were categorized as unexposed. Of these
children 133 (65.5%) accepted an invitation to participate in a
follow-up study when the children were between 6 and 11 years
old. In this group 112 (59 boys and 53 girls) were prenatally
pesticide exposed and 21 (14 boys and 7 girls) were unexposed. To
supplement the unexposed group, the participating families were
asked to invite children from family, friends and neighbours to
participate. Only children between 6 and 11 years whose mother
had not been occupationally exposed to pesticides during
pregnancy could participate. Through this method, 44 children
were recruited [12].
Ethics
The study was conducted according to the Helsinki II
Declaration with written informed consent by all mothers and
was approved by The Regional Scientific Ethical Committee for
Southern Denmark and the Danish Data Protection Agency.
Questionnaire
All families completed a questionnaire prior to the examination
of the child with information on medical history, education,
occupation, living conditions, life style and diet. An additional
short questionnaire regarding smoking, alcohol intake, medical
use, disease and occupation during pregnancy was answered by
the ‘new’ families for whom we did not have this information from
the first examination. Information on gestational age at birth, birth
weight and length was obtained from obstetric records.
Social class of the family was coded based on the parents
education and occupation according to the criteria of the Danish
National Institute of Social Research [15,16], which is almost
identical to the UK Registrar General’s classification of five social
classes ranked 1 (high) to 5 (low). The social class of the higher
ranked parent living with the child was used.
Clinical Examination
The children underwent a standardized physical examination.
Body weight (kg) was measured on a digital weight scale with a
precision of 0.1 kg (TBF-300, Tanita Europe, UK). Standing
height (cm) was measured to the nearest 0.1 cm using a
transportable stadiometer (Chasmors LTD., London, UK).
Thickness of skin folds (mm) at triceps, subscapular, biceps and
flank/suprailiac were measured by a caliper (John Bull, British
indicators LTD, UK) with a precision of 0.1 mm after allowing the
jaws to close on the fat fold for two seconds as described by
Rodriguez et al [17]. Abdominal circumference was measured at
the level of the umbilicus in a horizontal line with a tape measure
to the nearest mm. All anthropometrical measurements were
measured in triplicate and means were used for analysis.
Systolic and diastolic blood pressure was measured three times
with an automated non-invasive blood pressure monitor (Colin
Press-Mate, ColinH Corporation, Japan) and means were used for
analysis.
Heart rate was measured on a Heart Rate Monitor (Polar s810)
connected to a computer. After the child had been lying in a
relaxed, supine position for at least 5 minutes, 300 R-R intervals
were measured and 100 consecutive R-R intervals with the lowest
standard deviation (SD) were extracted for calculation of the
coefficient of variation for heart rate (CVRR). CVRR is the ratio in
(percent) of the SD of the R-R intervals to the mean R-R interval
(SD*100/mean R-R interval). Due to technical problems with the
Heart Rate Monitor during four of the examination days, heart
rate was obtained only for 128 of the 177 children.
The same paediatrician (CWV) performed all clinical exami-
nations blinded to information about maternal pesticide exposure
during pregnancy.
Genotyping and all serum analyses were performed blinded to
both exposure information and examination outcomes.
Laboratory Analysis
Venous non-fasting blood samples were obtained (between
midmorning and late afternoon) from 145 of the children. The
Prenatal Pesticide Exposure, PON1, and CVD Risk
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samples were collected in EDTA coated and uncoated vials
(Venoject). After centrifugation at 2000 g for 10 min at 20uC,
buffy coat for genotyping was separated from the EDTA-treated
samples. Buffy coat and serum from the uncoated vials were stored
at 280uC until analysis.
Metabolic Biomarkers
Insulin (proinsulin and insulin) and leptin concentrations in
serum were analyzed using commercial hormone kits from RayBio
(RayBio Human Insulin Elisa Kit or Human Leptin Elisa kit, cat.
no. ELH-insulin-001 human and ELH-leptin-001, AH Diagnos-
tics, A˚rhus, Denmark). The assays were performed with immobi-
lized specific antibody-coated 96-well plates. The amounts of both
insulin and leptin were quantified using standard curves for each
antigen evaluated in the same analysis (for details see the
manufacturers instructions). Limits of detection were 6 pg/ml
for leptin and 160 pg/ml for insulin and interassay variation was
less than 10% and 12% for leptin and insulin, respectively.
Insulin-like growth factor 1 (IGF-I) and insulin-like growth
factor binding protein 3 (IGFBP3) were measured in serum with
solid-phase enzyme-labelled chemiluminescent immunometric
assays (Immulite 2000; Diagnostic Products Corporation, Los
Angeles, CA, USA) using World Health Organization (WHO)
NIBSC IRR 87/518 and 93/560 standards, respectively. The
limits of detection were 25 ng/ml and 500 ng/ml, with intra- and
interassay variation less than 5 and 7%, respectively.
Genotyping of PON1
DNA was isolated from buffy coats and C-108T (rs705379),
M55L (rs854560) and Q192R (rs662) polymorphisms of the PON1
gene were determined by the Taqman-based allele discrimination
using the ABI Prism 7700 Sequence Detection System, as
previously described [18]. PON1 genotype was performed
successfully for 141 of the children.
PON1 Activity
The serum activity of PON1 was determined with paraoxon as
substrate as previously described [19,20]. Briefly, serum was added
to Tris buffer (100 mmol/l, pH 8.0) containing 2 mmol/l CaCl2
and 5.5 mmol/l paraoxon (O,O-diethyl-O-p-nitrophenylpho-
sphate, Sigma Chemical Co). The rate of p-nitrophenol generation
was determined at 405 nm, 25uC, using a continuously recording
spectrophotometer (Perkin Elmer, Lambda 11).
Data Analysis
Since only 11 children had the RR genotype, those with the QR
and RR type were combined in the data analysis.
Sum of four skinfolds (mm) was calculated as the sum of:
triceps + subscapular + biceps + flank skinfolds (mm). Body fat
percentage was calculated by a gender and age specific equation
[21] based on triceps and sub scapular skin folds: For girls:
(1.33(triceps+subscapular)- 0.013(triceps + subscapular)2 22.5)
when the sum of triceps and subscapular skinfold was lower
than 35 mm, and (0.546(triceps+subscapular) +9.7) when the
sum was higher than 35 mm. For boys: (1.21 (triceps +
subscapular)- 0.008 (triceps + subscapular)2 - 1.7) and (0.783
(triceps + subscapular) +1.6), respectively. Body mass index
(BMI) was calculated as weight in kilograms divided by squared
height in meters (kg/m2). Age and gender specific BMI Z-scores
were calculated (child value minus mean value for gender and
age group divided by standard deviation for gender and age
group) using a contemporary Danish reference population [22].
BMI Z-score-difference (DBMI) from birth to school age was
calculated by subtracting the Z-score at birth from the Z-score
at school age. A DBMI Z-score .0.67 was considered a
significant change (catch up or catch down), as 0.67 SD
represents the width of each centile band of standard growth
charts (i.e. 2nd to 9th, 9th to 25th, 25th to 50 centiles etc.) [23].
Differences in DBMI Z-scores were evaluated as a categorical
variable (+/2 clinically significant change) by Chi square
analysis and as a continuous variable by multiple linear
regression analysis.
Differences in characteristics between the group of children with
the QQ and the QR/RR genotypes were tested by Mann-
Whitney U test (continuous data) or Fisher’s Exact test (categorical
data with two categories) or Likelihood Ratio (categorical data
with more than two categories).
Logarithmic transformation of the variables was used when
necessary to approach a normal distribution of residuals and was
required for paraoxonase 1 activity, abdominal circumference,
sum of four skin folds, body fat percentages, CVRR, and serum
concentrations of leptin, insulin, and IGF-I.
Age- and gender-adjusted partial correlation analyses were used
to investigate associations between paraoxonase 1 activity and
outcome variables. Effects of prenatal pesticide exposure were
analyzed by multiple linear regression analysis. First, interactions
between the PON1 Q192R genotype (0 = QQ, 1 = QR/RR) and
prenatal pesticide exposure (0 = unexposed, 1 = medium or high
exposure) were tested by including a product term in the models.
Subsequently, analyses were run separately for the group of
children with the QQ and QR/RR genotype as well as for the
combined group of children. In the stratified analyses, two dummy
variables, one for high and one for medium prenatal pesticide
exposure, were used in the models with no exposure as reference.
Maternal smoking in pregnancy was treated as a dichotomous
variable. Due to the small sample size, social class was re-coded
into three categories: groups 1–3, group 4 or group 5 and included
in the models as two dummy variables with group 4 as reference as
most families belonged to this group. Covariates were identified
from a priori considerations of relevant factors that might influence
the outcome variables. For anthropometric outcomes, age at
examination, gender, social class and maternal smoking in
pregnancy were considered as obligatory covariates. For DBMI
Z-score, gestational age was included in the models. Blood
pressure was correlated to body composition, and therefore BMI
was included in the models. Metabolic biomarkers were analyzed
both with and without BMI in the models. The results are
presented as the mean difference, or the relative difference in
percent for log-transformed outcomes, with 95% confidence
intervals (95%CI). A p-value below 0.05 was considered statisti-
cally significant.
Results
This paper present the results for 141 children for whom
PON1 genotypes were determined. The genotype frequencies for
PON1 Q192R were 56.7% QQ, 35.5% QR, and 7.8% RR
corresponding to an R-allele frequency of 25.5%. The
distribution approximated the Hardy-Weinberg equilibrium.
QQ homozygous children had significantly lower paraoxonase
1 activity than the R-carriers (Table 1). Among the R-carriers,
none had the 55 MM genotype compared to 25% of those with
the QQ type. None of the other characteristics differed
significantly between children with the QQ genotype and the
QR/RR genotype. The PON1 Q192R genotype explained 66%
of the variance in the paraoxonase activity. No significant
Prenatal Pesticide Exposure, PON1, and CVD Risk
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correlations between paraoxonase activity and any outcome
variables were seen (data not shown).
Significant interactions between PON1 Q192R genotype and
prenatal pesticide exposure were seen for all outcomes, except
systolic blood pressure, CVRR, and non-fasting serum concentra-
tions of insulin, both before and after adjusting for covariates
(Table 2). This finding indicates a higher susceptibility towards
prenatal pesticide exposure in individuals with the R-allele. In
genotype stratified analysis, an exposure-related increase in
abdominal circumference, skin fold thickness, body-fat percentage
(Table 3), BMI Z-score, BMI Z-score difference from birth to
school age (Table 4) and in systolic and diastolic blood pressure
(Table 5) was seen in children with the R-allele. CVRR tended to
be lower in exposed than in the unexposed R-carriers but the
difference was not statistically significant, possibly due to a large
variation in the CVRR data. Exclusion of three children with
CVRR above 20% and one child with CVRR below 2% did not
materially change the results. For QQ-homozygote children, none
of the outcome variables was significantly affected by prenatal
pesticide exposure.
The mean birth weight was significantly lower for exposed than
unexposed children (3521 g versus 3677 g, p = 0.04). This
association was seen for both QQ homozygotes and R-carriers
although it did not reach significance for the genotypes separately
(data not shown). Among the R-carriers, 53.8% of the exposed
children had an increase in DBMI Z-score of more than 0.67
compared to 13.6% among the unexposed (p = 0.003). For the
QQ-homozygotes, the proportion of children with DBMI Z-score
above 0.67 was similar for exposed and unexposed, 32.7% and
29.0%, respectively (p = 0.81). The low percentage for the group of
unexposed R-carriers was due to negative BMI Z-scores at school
age and negative difference in BMI Z-scores from birth to school
age. Hence, this group of children was leaner than the reference
population and also the unexposed QQ-homozygotes. The same
pattern was seen for abdominal circumference, sum of four skin
folds, body fat percentage, and serum concentration of IGF-I
(Tables 2, 3, 4, 5, 6). Systolic and diastolic blood pressure, CVRR,
and serum concentration of leptin did not differ between
unexposed R-carriers and QQ-homozygotes (Table 5 and 6). In
R-carriers, non-fasting serum concentrations of leptin and IGF-I
were increased after prenatal pesticide exposure in an exposure
Table 1. Characteristics of 141 children with genotype PON1 192QQ or QR/RR examined at age 6–11 years.
Outcome a PON1 192QQ PON1 192QR/RR p-value
No of boys/girls (% boys) 47/33 (58.8) 35/26 (57.4) 1.00
Prenatal pesticide exposure [N (%)] 0.87
No exposure 31 (38.8) 22 (36.1)
Medium exposure 28 (35.0) 24 (39.3)
High exposure 21 (26.3) 15 (24.6)
New recruited controls [N (%)] 21 (26.3) 16 (26.2) 1.00
Age (years) 8.7 (6.7; 10.6) 8.3 (6.8; 10.6) 0.26
Height (cm) 134.2 (121.2; 145.5) 132.9 (116.1; 146.2) 0.45
Weight (kg) 29.7 (22.9; 39.5) 28.4 (19.9; 43.4) 0.50
Parental social class [N (%)] 0.29
1–3 28 (35.0) 14 (23.0)
4 37 (46.3) 33 (47.1)
5 15 (18.8) 14 (23)
Birth weight (g) 3520 (2590; 4677) 3735 (2295; 4455) 0.25
Gestational age (days) 283 (255; 297) 282 (261; 296) 0.94
Maternal smoking in pregnancy [no. (%)] 19 (23.8) 13 (21.3) 0.84
Maternal alcohol consumption in pregnancy [no. (%)] 32 (40.0) 18 (30.5) 0.29
Mother of non-Danish origin 4 (5.0) 2 (3.3) 0.70
Paraoxonase activity (nmol/min/ml) 29.6 (18.5; 29.6) 58.5 (42.4; 72.1) ,0.001
PON1 55 [N (%)] ,0.001
LL 22 (27.5) 31 (51)
ML 38 (47.5) 30 (49)
MM 20 (25.0) 0
PON1 108 [N (%)] 0.15
CC 19 (23.8) 21 (34.4)
CT 46 (57.6) 25 (41.0)
TT 15 (18.8) 15 (24.6)
For continuous variables, data represent median (5;95 percentiles).
bDifferences between groups were tested with Mann-Whitney U-Test (continuous data) or Fishers Exact Test (categorical data with two categories) or Likelihood Ratio
(categorical data with more than two categories).
doi:10.1371/journal.pone.0036830.t001
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Table 2. Crude and adjusted estimated effects (b, 95%CI) of prenatal pesticide exposure, and PON1 Q192R genotype on
anthropometric outcomes, blood pressure, and metabolic biomarkers at school age.
Crude model Adjusted model
b (95%CI) p-value b (95%CI) p-value
Abdominal circumferencea (cm)
PON1 192QR/RR (unexposed) 26.30 (211.32;21.00) 0.02 26.22 (211.01; 21.18) 0.02
Pesticide exposure (PON1 192QQ) 22.00 (26.34; 2.54) 0.38 22.26 (26.40; 2.06) 0.30
Pesticide exposure (PON1 192QR/RR) (interaction) 10.09 (2.71; 18.01) 0.01 10.35 (3.34; 17.85) 0.004
Sum of four skin foldsa (mm)
PON1 192QR/RR (unexposed) 220.12 (234.3; 22.87) 0.03 221.81 (235.24; 25.61) 0.01
Pesticide exposure (PON1 192QQ) 25.88 (219.88; 10.55) 0.46 27.68 (220.97; 7.85) 0.31
Pesticide exposure (PON1 192QR/RR) (interaction) 49.01 (16.4290.71) 0.002 52.94 (20.80; 93.64) 0.001
Body fat percentagesa (%)
PON1 192QR/RR (unexposed) 215.79 (227.72; 21.90) 0.03 216.44 (228.05; 22.95) 0.02
Pesticide exposure (PON1 192QQ) 24.86 (216.10; 7.88) 0.44 25.82 (216.76; 6.56) 0.34
Pesticide exposure (PON1 192QR/RR) (interaction) 35.47 (11.73; 64.26) 0.002 37.00 (13.58; 65.24) 0.001
BMI Z-score at school ageb
PON1 192QR/RR (unexposed) 20.70 (21.36; 20.04) 0.04 20.78 (21.43; 20.13) 0.02
Pesticide exposure (PON1 192QQ) 20.15 (20.69; 0.39) 0.59 20.26 (20.80; 0.28) 0.34
Pesticide exposure (PON1 192QR/RR) (interaction) 1.30 (0.47; 2.13) 0.002 1.36 (0.54; 2.17) 0.001
DBMI Z-score between school age and birthc
PON1 192QR/RR (unexposed) 20.61 (21.45; 0.23) 0.16 20.53 (21.30; 0.24) 0.18
Pesticide exposure (PON1 192QQ) 0.13 (20.56; 0.83) 0.71 20.07 (20.70; 0.57) 0.83
Pesticide exposure (PON1 192QR/RR) (interaction) 1.43 (0.36; 2.49) 0.01 1.32 (0.35; 2.28) 0.01
Systolic blood pressured (mmHg)
PON1 192QR/RR (unexposed) 20.61 (24.75; 3.54) 0.77 20.30 (24.53; 3.94) 0.89
Pesticide exposure (PON1 192QQ) 20.67 (24.09; 2.74) 0.70 20.57 (23.99; 2.86) 0.74
Pesticide exposure (PON1 192QR/RR) (interaction) 3.28 (21.97; 8.53) 0.22 3.19 (22.26; 8.64) 0.25
Diastolic blood pressured (mmHg)
PON1 192QR/RR (unexposed)
20.88 (24.29; 2.53) 0.61 20.50 (24.00; 3.00) 0.78
Pesticide exposure (PON1 192QQ) 21.45 (24.26; 1.36) 0.31 21.30 (24.13; 1.53) 0.37
Pesticide exposure (PON1 192QR/RR) (interaction) 5.35 (1.03; 9.66) 0.02 4.89 (0.38; 9.40) 0.03
CVRR
e
PON1 192QR/RR (unexposed) 28.7 (235.9; 30.0) 0.61 211.2 (237.8; 26.7) 0.51
Pesticide exposure (PON1 192QQ) 6.1 (220.7; 42.1) 0.69 7.2 (219.8; 43.4) 0.63
Pesticide exposure (PON1 192QR/RR) (interaction) 223.4 (249.7; 16.4) 0.21 222.4 (249.0; 18.0) 0.23
Leptinf (ng/ml)
PON1 192QR/RR (unexposed) 234.8 (261.2; 9.3) 0.10 233.9 (260.4; 10.2) 0.11
Pesticide exposure (PON1 192QQ) 28.2 (217.0; 98.0) 0.26 31.3 (214.5; 101.6) 0.21
Pesticide exposure (PON1 192QR/RR) (interaction) 135.2 (20.8; 357.8) 0.01 141.7 (25.2; 366.7) 0.01
Insulinf (ng/ml)
PON1 192QR/RR (unexposed) 14.0 (231.7; 90.4) 0.61 10.7 (233.9; 85.4) 0.70
Pesticide exposure (PON1 192QQ) 31.6 (214.7; 103.0) 0.21 30.6 (215.4; 101.8) 0.23
Pesticide exposure (PON1 192QR/RR) (interaction) 11.7 (241.8; 114.6) 0.74 15.4 (240.1; 122.4) 0.67
IGF-If (ng/ml)
PON1 192QR/RR (unexposed) 221.3 (236.2; 22.9) 0.03 220.4 (234.3; 23.5) 0.02
Pesticide exposure (PON1 192QQ) 214.8 (228.3; 1.3) 0.07 213.0 (225.7; 1.8) 0.08
Pesticide exposure (PON1 192QR/RR) (interaction) 48.9 (14.2; 94.2) 0.004 50.1 (17.9; 91.1) 0.001
IGFBP3f (ng/ml)
PON1 192QR/RR (unexposed) 2273.9 (2636.2; 88.5) 0.14 2253.6 (2605.1; 98.0) 0.16
Prenatal Pesticide Exposure, PON1, and CVD Risk
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dependent manner (Table 6). After adjusting for BMI, the effect
on leptin, but not IGF-I, remained significant (data not shown).
For insulin and IGFBP-3, the results were less consistent.
Within the group of children with the QQ genotype, those with
the 55MM genotype had higher birth weight than those with the
55LL or 55 ML type (data not shown) but none of the outcome
variables measured at school age differed between the PON1
L55M genotypes. Including the PON1 L55M genotypes in the
regression analysis (modelled as 0 (MM), 1 (ML), and 2 (LL)) did
not change the results.
Discussion
Despite the small sample size, our study found indications of a
gene-environment interaction between prenatal pesticide exposure
and the PON1 Q192R genotype that might affect the risk of
obesity and related diseases later in life. Prenatally pesticide-
exposed children carrying the R-allele had higher abdominal
circumference, body fat content, BMI Z-scores, systolic and
diastolic blood pressure, and serum concentrations of leptin and
IGF-I at school age than did unexposed children. For QQ-
homozygous children, none of these variables were significantly
affected by prenatal pesticide exposure. The results indicate that
R-carriers may be especially susceptible towards developmental
disturbances after prenatal pesticide exposure.
An important strength of this study is the longitudinal design
that minimizes exposure misclassification and bias. The classifica-
tion of the mothers as high, medium or not exposed was done
independently by two toxicologists with special expertise in
working conditions in greenhouse horticultures at enrolment early
in pregnancy [13,14] and hence completely independent of
subsequent examination outcomes for the children.
The unexposed group was extended at the follow-up examina-
tion to provide better comparison data. None of the mothers of
these children had worked in greenhouses or other occupations
where pesticides were used during pregnancy. They were
distributed evenly between the group of children with the R-allele
Table 2. Cont.
Crude model Adjusted model
b (95%CI) p-value b (95%CI) p-value
Pesticide exposure (PON1 192QQ) 278.2 (2376.5; 220.1) 0.61 252.8 (2341.4; 235.9) 0.72
Pesticide exposure (PON1 192QR/RR) (interaction) 467.4 (0.1; 924.7) 0.05 469.9 (27.3; 912.4) 0.04
B expresses the mean differences for BMI Z-score at school age, DBMI Z-score between school age and birth, systolic and diastolic blood pressure, and IGFBP3 and the
relative difference (in percent) for ln-transformed outcomes (abdominal circumference, sum of four skin folds, body fat percentages, coefficient of variation for heart
rate (CVRR), leptin, insulin, and IGF-I).
Adjusted model included agender, age at examination, social class, and maternal smoking in pregnancy; bsocial class, and maternal smoking in pregnancy; c gestational
age, social class, and maternal smoking in pregnancy; dgender, age at examination, maternal smoking in pregnancy, and BMI; egender, age at examination, and maternal
smoking in pregnancy; fgender and age at examination.
doi:10.1371/journal.pone.0036830.t002
Table 3. Adjusted valuesa for anthropometric outcomes at school age in children in relation to prenatal pesticide exposure and
PON1 Q192R genotype.
Adjusted geometric mean (95% CI)
All children PON1 192QQ PON1 192QR/RR
Abdominal circumference (cm)
No exposure 62.3 (60.6; 63.9) 63.2 (61.0; 65.4) 59.2 (56.8; 61.7)##
Medium exposure 63.2 (61.6; 64.8) 61.0 (58.8; 63.3) 62.4 (60.0; 64.8)
High exposure 63.8 (61.9; 65.8) 62.7 (60.1; 65.4) 65.9 (62.7; 69.3) **
Sum of four skin folds (mm)
No exposure 40 (36; 44) 43 (38; 49) 34 (30; 39)##
Medium exposure 44 (40; 48) 36 (32; 42) 44 (39; 50) #**
High exposure 46 (41; 52) 44 (38; 51) 52 (44; 62) ***
Body fat percentages- (%)
No exposure 18.1 (16.8; 19.5) 19.1 (17.2; 21.1) 16.0 (14.4; 17.9)#
Medium exposure 19.1 (17.8; 20.6) 16.8 (15.1; 18.7) 19.5 (17.5; 21.6)#**
High exposure 20.4 (18.7; 22.3) * 19.6 (17.4; 22.2) 22.3 (19.6; 25.5) ***
aResults from linear regression model adjusted for gender, age at examination, social class, and maternal smoking in pregnancy. The outcome variables were ln-
transformed.
*p#0.05
**p#0.01
***p#0.001 compared to unexposed.
#p#0.05
##p#0.01 compared to PON1 192QQ in the same exposure group.
doi:10.1371/journal.pone.0036830.t003
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and the QQ homozygotes, and, therefore, did not affect the
differences observed in response to prenatal pesticide exposure
between the two genotypes. In addition, all examinations of the
children were done blinded to the exposure information and by
the same paediatrician using standardized procedures. Genotyping
of PON1 and analyses of serum samples were performed blinded to
both exposure information and examination outcomes.
The small number of exposed and unexposed children within
each of the two PON1 genotypes is a limitation of the study,
because it decreases the power of the study and diminishes the
possibility of detecting exposure related effects. Nonetheless, if
detectable in a small study like ours, the associations may be
important. An additional limitation is that we conducted many
statistical analyses and chose not to adjust for multiple compar-
Table 5. Adjusted valuesa for systolic and diastolic blood pressure and coefficient of variation for heart rate (CVRR) at school age in
relation to prenatal pesticide exposure and PON1 Q192R genotype.
Adjusted mean/geometric mean (95% CI)
All children PON1 192QQ PON1 192QR/RR
Systolic blood pressure (mmHg)
No exposure 100.6 (98.7; 102.6) 100.1 (97.4; 102.7) 99.1 (95.6; 102.7)
Medium exposure 100.1 (98.2; 102.0) 99.4 (96.6; 102.3) 99.6 (96.6; 102.5)
High exposure 101.7 (99.4; 104.0) 99.7 (96.4; 103.0) 108.4 (104.1; 112.7) ## ***
Diastolic blood pressure (mmHg)
No exposure 58.9 (57.2; 60.6) 58.2 (55.9; 60.4) 57.4 (54.8; 60.0)
Medium exposure 59.2 (57.5; 60.8) 58.1 (55.7; 60.5) 61.1 (58.7; 63.4) #*
High exposure 57.8 (55.8; 59.7) 55.5 (52.8; 58.3) 62.0 (58.6; 65.5) #*
CVRR
b
No exposure 7.4 (6.3; 8.7) 8.2 (6.3; 10.7) 7.4 (5.8; 9.5)
Medium exposure 7.4 (6.5; 8.4) 8.8 (7.1; 10.8) 6.1 (4.9; 7.5) ##
High exposure 7.5 (6.3; 8.8) 8.7 (6.7; 11.2) 6.1 (4.7; 8.0) #
aResults from linear regression models adjusted for gender, age at examination, maternal smoking in pregnancy, and for systolic and diastolic blood pressure also BMI.
CVRR was ln-transformed.
*p#0.05,
***p#0.001 compared to unexposed.
#p#0.05,
##p#0.01 compared to PON1 192QQ in the same exposure group.
bDue to technical problems with the Heart Rate Monitor, CVRR was only obtained for 98 (14 QQ and 14 QR/RR unexposed, 23 QQ and 19 QR/RR medium exposed, and 16
QQ and 12 QR/RR high exposed) of the 141 children for whom PON1 genotype was determined.
doi:10.1371/journal.pone.0036830.t005
Table 4. Multiple regression analysis of prenatal pesticide exposure, maternal smoking and social class as predictors for BMI Z-
scores at school age, and difference in BMI Z-scores between birth and school age in children with the PON1 192 QQ or QR/RR
genotype.
PON1 192QQ PON1 192QR/RR
b (95% CI) p-value b (95% CI) p-value
BMI Z-score at school age
Social class 5 0.49 (20.24; 1.22) 0.19 0.07 (20.69; 0.82) 0.86
Social class 1–3 20.43 (21.01; 0.16) 0.15 20.19 (20.96; 0.59) 0.64
Maternal smoking in pregnancy 0.10 (20.54; 0.74) 0.77 0.77 (0.021; 1.52) 0.04
Maternal pesticide exposure medium level 20.45 (21.06; 0.15) 0.14 0.79 (0.09; 1.50) 0.03
Maternal pesticide exposure high level 20.07 (20.73; 0.58) 0.82 1.57 (0.76; 2.37) ,0.001
DBMI Z-score between school age and birth
Gestational age (days) 20.04 (20.06; 20.01) 0.003 20.07 (20.10; 20.03) ,0.001
Social class 5 0.77 (20.12; 1.66) 0.09 0.21 (20.68; 1.09) 0.64
Social class 1–3 20.77 (21.50; 20.04) 0.04 20.29 (21.19; 0.61) 0.52
Maternal smoking in pregnancy 0.33 (20.44; 1.11) 0.39 0.82 (20.07; 1.70) 0.07
Maternal pesticide exposure medium level 20.35 (21.08; 0.39) 0.35 1.13 (0.28; 1.99) 0.01
Maternal pesticide exposure high level 0.15 (20.66; 0.97) 0.71 1.29 (0.36; 2.21) 0.007
doi:10.1371/journal.pone.0036830.t004
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isons, although they may increase the likelihood of spurious
associations. However, several of the outcomes are interrelated
and the observed associations between prenatal pesticide exposure
and effects in the group of children with the R-allele were very
robust being significant both before and after adjusting for
covariates. In addition, the magnitudes of the effects were related
to the exposure level which again supports a causal association.
Finally, the distribution of known risk factors such as social class
and maternal smoking in pregnancy did not differ between the
children with the R-allele and the QQ-homozygotes.
Another possible limitation of the study is that the PON1
genotypes of the mothers were not determined. The maternal
genotype and related ability to metabolize pesticides might be
important for protection of the foetus against exposure. However,
only 11 children (6 unexposed and 5 exposed) were homozygous
for the R-allele, and for the heterozygous children approximately
half of the mothers would be assumed to be QQ homozygotes.
Therefore, it is unlikely that the observed associations would be
explained by the maternal genotype.
In a previous study, women who worked in floricultures in
Mexico and had the RR genotype had higher risk of having
children with low birth weight than women with the QQ or QR
genotype [24]. In another study, maternal organophosphate
exposure during pregnancy was associated with reduced head
circumference and head size of the children at birth if the mothers
had a low PON1 concentration but no association was seen
between neither maternal nor child PON1 genotype and head
circumference or birth weight or birth length [25]. However, at 12
months of age, negative associations between prenatal organo-
phosphate exposure and cognitive development were seen if the
mothers had the QR/RR genotype, although later in childhood
children of mothers with the QQ-genotype appeared more
affected [26]. In a recent study, shorter gestation and smaller
head circumference at birth were associated to low infant, but not
maternal, PON1 enzyme activity [27]. This association was
independent of maternal organophosphate exposure in pregnancy
but for infants with low activity (and PON1 -108TT and PON1
192QQ genotype) an association between maternal organophos-
phate exposure in pregnancy and shorter gestational age was seen.
Although, the R-allele seems to provide better protection than the
Q-allele toward toxic effects of certain organophosphates such as
chlorpyrifos [8,28], the capacity of PON1 allozymes to protect
LDL from oxidation might be different, and even the reverse, of
the paraoxonase activity, with the lowest capacity for the R-
allozyme [1,3].
A weak association between the R-allele and increased CVD
risk has been confirmed in most case-control studies, and is
supported by meta-analyses [2,9,29–33]. Results from studies on
associations between PON1 R192Q genotype and risk markers for
CVD in healthy populations are inconsistent, as some found no
association [34,35] or a higher frequency of the R-allele
among obese (BMI $30 kg/m2) compared to normal-weight
pre-menopausal women [36], while increased blood pressure was
associated with the R-allele in women above 60 years [30], and in
a rural population in Greece [37]. In general, these studies do not
include information about environmental exposures, and discrep-
ancies might be due to unidentified gene-environment or gene-
gene interactions. In a recent study the combination of low serum
HDL concentration and the RR genotype markedly increased the
risk of CVD [38]. This interaction is also supported by the results
Table 6. Adjusted valuesa for non-fasting serum concentrations of leptin, insulin, IGF1, and IGFBP3 at school age in relation to
prenatal pesticide exposure and PON1 Q192R genotype.
Adjusted mean/geometric mean (95% CI)
All children PON1 192QQ PON1 192QR/RR
Leptin (ng/ml)
No exposure 2.06 (1.60; 2.66) 2.48 (1.73; 3.57) 1.57 (1.11; 2.22)
Medium exposure 3.67 (2.81; 4.79)** 2.92 (1.95; 4.37) 4.41 (3.13; 6.22) ***
High exposure 4.55 (3.26; 6.36)*** 3.77 (2.32; 6.13) 6.47 (4.07; 10.29) ***
Insulin (ng/ml)
No exposure 0.42 (0.33; 0.54) 0.40 (0.29; 0.54) 0.47 (0.30; 0.71)
Medium exposure 0.67 (0.52; 0.86)** 0.58 (0.42; 0.81) 0.90 (0.61; 1.33)*
High exposure 0.46 (0.33; 0.64) 0.45 (0.30; 0.67) 0.35 (0.20; 0.60)
IGF-I (ng/ml)
No exposure 143.9 (131.0; 158.1) 158.7 (139.8; 180.1) 125.1 (108.2; 144.6)##
Medium exposure 139.0 (126.5; 152.7) 127.0 (111.2; 145.1)* 155.4 (135.2; 178.6) #*
High exposure 163.1 (145.4; 183.0) 154.8 (132.8; 180.5) 173.0 (144.6; 206.9)**
IGFBP3 (ng/ml)
No exposure 3339 (3169; 351) 3341 (3212; 3670) 3169 (2897; 3441)
Medium exposure 3369 (3198; 3540) 3209 (2971; 3447) 3586 (3323; 3849) #*
High exposure 3592 (3384; 3802) 3615 (3341; 3890) 3558 (3219; 3897)
aResults from linear regression models adjusted for gender and age. Leptin, insulin, and IGF-I were ln-transformed.
*p#0.05,
**p#0.01,
***p#0.001 compared to unexposed.
#p#0.05,
##p#0.01 compared to PON1 192QQ unexposed.
doi:10.1371/journal.pone.0036830.t006
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from our study where no marked difference in the risk profile
between unexposed R-carriers and QQ-homozygotes was seen. In
fact, the R-carriers were leaner than the QQ homozygotes at
school age. However, the combination of the R-allele and prenatal
pesticide exposure had a pronounced effect on the risk profiles.
In our study, pesticide-exposed children with the R-allele had a
higher blood pressure and a lower CVRR, although only the
former reached statistical significance. Increased blood pressure
was also reported for children, whose mothers were occupationally
exposed to pesticides during pregnancy in Ecuador [39]. The
PON1 genotype was not determined in these studies, but the R-
allele frequency is likely to be higher than in our study, since an R-
allele frequency of 40 to 60% has been reported for many
populations in Latin and South America [24]. Due to maturation
of the cardiac autonomic activity, CVRR increases during gestation
and early postnatal life followed by a decline [40]. Prenatal
exposure to the neurotoxicant methyl mercury caused decreased
CVRR in children at 7 and 14 years of age [41].
Children prenatally exposed to pesticides had lower birth weight
than unexposed children as previously reported for the children in
this study [12], and also reported in several other studies [42–45].
For children with the R-allele, this was followed by accelerated
body fat accumulation until school age. Low birth weight followed
by catch-up growth and body fat accumulation during childhood
is associated with increased risk of obesity, insulin and leptin
resistance and CVD later in life [46–48,48]. There is increasing
evidence that prenatal and early postnatal environmental factors
might influence the risk [49,50]. In addition, prenatal exposure to
low doses of some endocrine disrupting chemicals has been
demonstrated to cause obesity in rodents [51–53], and epidemi-
ological studies also have linked exposure to some of these
chemicals to obesity and metabolic syndrome in humans [54–56].
The mechanisms behind these associations are not fully under-
stood, but might include epigenetic changes that affect gene
expression [57,58] and fetal programming of energy balance [59],
perhaps including disturbance of the hypothalamic-pituitary-
adrenal axis [60]. In rats, low doses of chlorpyriphos during
development caused excess weight gain and leptin and insulin
dysregulation later in life [61,62] and neonatal parathion exposure
disrupted the production of adipokines, including leptin, that
regulate appetite by communicating metabolic status between
adipose tissues and the brain [63]. Hence, these effects resemble
those seen in the exposed children expressing the R-allele.
In the present study, the mothers were exposed early in their
pregnancies to a variety of different pesticides including organo-
phosphates and several fungicides with known endocrine disrupt-
ing properties [64,65]. All of the substances had been approved by
the national regulatory agency in accordance with European
Union legislation. Due to the complex exposure setting, it was not
possible to identify specific pesticides as responsible for the effects.
They may be due to the combined exposure to several pesticides
and maybe also to other ingredients added to the pesticide
formulations. For most of the exposed mothers, organophosphates
had been used occasionally in the working areas, but only very few
mothers had been involved directly in their application. Whether
PON1 can detoxify other types of pesticides than organophos-
phates has, to our knowledge, not been investigated.
In conclusion, this study indicates a gene-environment interac-
tion between prenatal pesticide exposure and PON1 gene
heterogeneities that affects cardiovascular risk markers already
thought to be associated with the R-allele, as such [2]. Individuals
with the R allele in the 192 position seem particularly susceptible,
and the combination of this genotype and prenatal pesticide
exposure significantly stimulated fat accumulation from birth to
school age, caused higher blood pressure and enhanced serum
concentration of leptin and IGF-I. These effects are all related to
increased risk for development of metabolic syndrome and CVD
later in life. The results also illustrate that a susceptible subgroup of
a population could be affected, although effects may not be evident
in the entire population.
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